Optimizing cardiac resynchronization therapy with the use of an implantable heart monitor
- Conditions
- 10019280heart failure / pump failure
- Registration Number
- NL-OMON42377
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
*Class I or IIa criteria of the 'European Society of Cardiology' for cardiac resynchronisation.
*Class III heart failure according to the 'New York Heart Association' with a hospitalization for hartfailure in the previous year.
*Willing and able to understand and comply with the study requirements and providing a signed informed consent.
*Under aged.
*Pregnant.
*Expected to undergo cardiac surgery in the near future.
*Permanent atrial fibrillation.
*Already having a cardiac resynchronisation device implanted previously.
*Pulmonary embolism in the prior 6 months or repeatedly in their lifetime.
*Cerebrovascular incident (CVA or TIA) in the previous 6 months.
*History of clotting or bleeding disorders (i.e. hyper- and hypocoagulability).
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary study outcome will be the dataset collected by the hartmonitor<br /><br>during the conventional, invasive, pressure guided (dP/dt) optimalisation of<br /><br>the resynchronisation device. Which should lead to a usable algorhytm for<br /><br>optimizing resynchronisation pacing only using the hartmonitor in the futur. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Not applicable.</p><br>